Showing results (2101-2110 of 3,477) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|November 12, 2018
Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ TransplantationCamille Tron, Florian Lemaitre, Céline Verstuyft, et al.Clinical Pharmacokinetics|July 1, 1988
Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactionsS R Smith, M J KendallClinical Pharmacokinetics|December 13, 2016
Clinical Pharmacokinetics and Pharmacodynamics of CediranibWeifeng Tang, Alex McCormick, Jianguo Li, et al.Clinical Pharmacokinetics|November 30, 2016
Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug TreatmentPamela L Clemens, Xiaoyu Yan, Henk M Lokhorst, et al.Clinical Pharmacokinetics|November 30, 2016
Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic ModellingJan Snoeys, Maria Beumont, Mario Monshouwer, et al.Clinical Pharmacokinetics|February 6, 2014
Evidence-based morphine dosing for postoperative neonates and infantsElke H J Krekels, Dick Tibboel, Saskia N de Wildt, et al.Clinical Pharmacokinetics|February 26, 2014
Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targetsHuixin Yu, Neeltje Steeghs, Cynthia M Nijenhuis, et al.Clinical Pharmacokinetics|October 13, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part IShu-Feng ZhouClinical Pharmacokinetics|January 21, 2017
Clinical Pharmacokinetics and Pharmacodynamics of DexmedetomidineMaud A S Weerink, Michel M R F Struys, Laura N Hannivoort, et al.Clinical Pharmacokinetics|April 6, 2019
Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, et al.Pageof 348